Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Please remind me:
"...but PTSC must maintain the PPS above $5 for 30+ days." 
 
Interesting thought, though I doubt Patriot will have the money (or is willing) to purchase tens of millions of shares around $5, but who knows.
 
But this whole topic raises an interesting question:
On the one side (Patriot's communication via SEC filings) M&A seems to be the main focus for the company NOW and for the next time - on the other side (Patriot's communication via Dutton) the"problem of the high OS" and therefore the need for a buyback/RS/no-one-thought-of-solution seems to be the last main issue, the company has to resolve. Of course this is only correct, if my assumption, that it is not Dutton itself, who are communicating, but Patriot itself (meaning what Dutton writes as number one problem is actually the number one issue the management wants to get solved, as they got rid of all the other negatives from the list).
Now the question:
What really ist the main focus for the management now and in the next months?
 
I hope, RG adresses a lot more than only the past...
 
GLTY 
Share
New Message
Please login to post a reply